longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesLongbridge ProFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
Reuters
Oct 15, 2026 at 03:46 PM

Due to the copyright holder's request, this page is temporarily unavailable.

Recommended Readings

  • Eli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …Apr 20, 2026 at 06:34 PM
  • Eli Lilly's Oral Weight-Loss Drug Foundayo Approved, the Only One That Can Be Taken Anytime Without FastingApr 1, 2026 at 11:11 PM
  • From Weight-Loss Drugs to Sleep Disorders! Lilly Plans to Acquire Centessa for Up to $7.8 Billion, Entering Narcolepsy a…Apr 1, 2026 at 01:21 PM
  • Novo Nordisk will significantly reduce the price of its weight loss drug in the U.S. next year, with a maximum reduction…Feb 24, 2026 at 01:55 PM
  • A single pen covering the full month's dosage! Eli Lilly launches Zepbound multi-dose injection pen starting at $299Feb 23, 2026 at 11:17 PM

Related Stocks

Abbvie

USABBV

+0.16%

Amgen

USAMGN

-1.79%

Bristol Myers Squibb

USBMY

-2.41%

Related Stocks

Abbvie

USABBV

+0.16%

Amgen

USAMGN

-1.79%

Bristol Myers Squibb

USBMY

-2.41%

LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy